国际新闻
Why are eight US states suing OpenAI?
来源: Al Jazeera – Breaking News, World News and Video from Al Jazeera · 发布于
They allege ChatGPT has caused harm to their residents, coaching its users to harm themselves or others.
They allege ChatGPT has caused harm to their residents, coaching its users to harm themselves or others.
相关报道
Iowa, Nebraska and six other states are suing OpenAI for endangering children
The lawsuits cover everything from the design of ChatGPT to the company's recent issues with rogue agents.
Engadget - Technology News & Expert Reviews ·
Report: FTC probes Anthropic, OpenAI after Trump dismissed AI fears as “hoax”
Following a string of incidents where AI models hacked websites and breached government systems during testing phases, the Federal Trade Commission is officially probing Anthropic and OpenAI over consumer harms, an insider told Axios . On Wednesday, the FTC sent out civil investi
Ars Technica - All content ·
Recording device hidden in toilet paper found in top-secret OpenAI meeting room
It took OpenAI two days to notice that a recording device was hidden in a restricted executive conference room where leadership met to discuss highly confidential information, including technical progress, government engagements, and commercial partnerships. Only those with speci
Ars Technica - All content ·
OpenAI, Google pushing new AI models easily tricked into making nudes, researchers say
Safety researchers continue to warn that a large volume of AI-generated explicit content is spreading unchecked, while regulators do little to meaningfully stop it. This non-consensual content is commonly shared in text and direct messages or stored in private clouds where it’s l
Ars Technica - All content ·
Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
Martin Shkreli—the ex-pharmaceutical executive infamous for illegally hiking the price of a lifesaving anti-parasitic drug by more than 4,000 percent and getting a seven-year prison sentence for the fraudulent scheme he used to do it— has been under a lifetime ban from the pharma
Ars Technica - All content ·